N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide (BioDeep_00000855642)

   


代谢物信息卡片


N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide

化学式: C34H55NO3 (525.4182)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCCCN(C)C(=O)CCCCCCCCCCC1CC2=C(C=CC(=C2)O)C3C1C4CCC(C4(CC3)C)O
InChI: InChI=1S/C34H55NO3/c1-4-5-22-35(3)32(38)15-13-11-9-7-6-8-10-12-14-25-23-26-24-27(36)16-17-28(26)29-20-21-34(2)30(33(25)29)18-19-31(34)37/h16-17,24-25,29-31,33,36-37H,4-15,18-23H2,1-3H3/t25-,29-,30+,31+,33-,34+/m1/s1

描述信息

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

同义名列表

2 个代谢物同义名

N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide; ICI 164384



数据库引用编号

8 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 7 AR, EGFR, ESR1, IFNGR2, MYC, PGR, RARA
Peripheral membrane protein 1 ESR1
Endosome membrane 2 CTSD, EGFR
Endoplasmic reticulum membrane 4 CYP19A1, EGFR, IFNGR2, TGFA
Nucleus 8 AR, EGFR, ESR1, ESR2, FOS, MYC, PGR, RARA
cytosol 7 AR, CKB, ESR1, FOS, PGR, RARA, TGFBR2
dendrite 1 RARA
nucleoplasm 7 AR, ESR1, ESR2, FOS, MYC, PGR, RARA
RNA polymerase II transcription regulator complex 2 FOS, RARA
Cell membrane 5 CKB, EGFR, ESR1, IFNGR2, TGFBR2
Cytoplasmic side 1 ESR1
ruffle membrane 1 EGFR
Early endosome membrane 1 EGFR
Multi-pass membrane protein 1 CYP19A1
Golgi apparatus membrane 1 IFNGR2
cell junction 1 EGFR
cell surface 3 C3, EGFR, TGFA
glutamatergic synapse 1 EGFR
Golgi apparatus 1 ESR1
Golgi membrane 3 EGFR, IFNGR2, INS
lysosomal membrane 2 CTSD, EGF
Cytoplasm, cytosol 1 CKB
Lysosome 1 CTSD
endosome 1 EGFR
plasma membrane 12 AR, C3, CKB, EGF, EGFR, ESR1, IFNGR2, IFNLR1, PGR, RARA, TGFA, TGFBR2
Membrane 10 AR, CYP19A1, EGF, EGFR, ESR1, IFNGR2, IFNLR1, MYC, TGFA, TGFBR2
apical plasma membrane 1 EGFR
basolateral plasma membrane 2 EGFR, TGFA
caveola 1 TGFBR2
extracellular exosome 4 C3, CKB, CTSD, EGF
endoplasmic reticulum 3 CYP19A1, FOS, IFNGR2
extracellular space 10 C3, CKB, CTSD, EGF, EGFR, IGF1, INS, TFF1, TGFA, TGFBR2
lysosomal lumen 1 CTSD
perinuclear region of cytoplasm 3 EGFR, RARA, TGFA
mitochondrion 2 CKB, ESR2
protein-containing complex 6 AR, C3, EGFR, ESR1, MYC, RARA
intracellular membrane-bounded organelle 1 ESR2
Microsome membrane 1 CYP19A1
Single-pass type I membrane protein 4 EGFR, IFNGR2, IFNLR1, TGFBR2
Secreted 4 C3, IGF1, INS, TFF1
extracellular region 8 C3, CTSD, EGF, IGF1, INS, TFF1, TGFA, TGFBR2
mitochondrial outer membrane 1 PGR
transcription regulator complex 2 ESR1, RARA
nuclear membrane 1 EGFR
external side of plasma membrane 1 TGFBR2
actin cytoskeleton 1 RARA
cytoplasmic vesicle 1 TGFA
nucleolus 2 MYC, RARA
Membrane raft 3 CTSD, EGFR, TGFBR2
focal adhesion 1 EGFR
intracellular vesicle 1 EGFR
collagen-containing extracellular matrix 1 CTSD
nuclear speck 1 AR
receptor complex 2 EGFR, TGFBR2
chromatin 7 AR, ESR1, ESR2, FOS, MYC, PGR, RARA
Secreted, extracellular space 1 TGFA
Nucleus, nucleolus 1 MYC
blood microparticle 1 C3
[Isoform 3]: Secreted 1 TGFBR2
nuclear envelope 1 MYC
endosome lumen 2 CTSD, INS
Cytoplasmic vesicle membrane 1 IFNGR2
Nucleus, nucleoplasm 1 MYC
Melanosome 1 CTSD
euchromatin 1 ESR1
basal plasma membrane 1 EGFR
synaptic membrane 1 EGFR
exocytic vesicle 1 IGF1
ficolin-1-rich granule lumen 1 CTSD
secretory granule lumen 2 C3, INS
Golgi lumen 1 INS
endoplasmic reticulum lumen 2 C3, INS
nuclear matrix 1 FOS
platelet alpha granule lumen 2 EGF, IGF1
specific granule lumen 1 CTSD
tertiary granule lumen 1 CTSD
transport vesicle 1 INS
RNA polymerase II transcription repressor complex 1 MYC
azurophil granule lumen 1 C3
Endoplasmic reticulum-Golgi intermediate compartment membrane 2 INS, TGFA
ER to Golgi transport vesicle membrane 1 TGFA
clathrin-coated endocytic vesicle membrane 3 EGF, EGFR, TGFA
[Isoform 1]: Nucleus 1 ESR1
protein-DNA complex 1 FOS
Rough endoplasmic reticulum 1 MYC
multivesicular body, internal vesicle lumen 1 EGFR
Shc-EGFR complex 1 EGFR
transcription factor AP-1 complex 1 FOS
Myc-Max complex 1 MYC
alphav-beta3 integrin-IGF-1-IGF1R complex 1 IGF1
insulin-like growth factor binding protein complex 1 IGF1
insulin-like growth factor ternary complex 1 IGF1
[Isoform 4]: Mitochondrion outer membrane 1 PGR
transforming growth factor beta ligand-receptor complex 1 TGFBR2
interleukin-28 receptor complex 1 IFNLR1
nucleoplasmic reticulum 1 MYC


文献列表

  • Patrick S Y Wong, Fumio Matsumura. Serum free BG-1 cell proliferation assay: a sensitive method for determining organochlorine pesticide estrogen receptor activation at the nanomolar range. Toxicology in vitro : an international journal published in association with BIBRA. 2006 Apr; 20(3):382-94. doi: 10.1016/j.tiv.2005.08.016. [PMID: 16242299]
  • Ian M Dick, Jie Liu, Paul Glendenning, Richard L Prince. Estrogen and androgen regulation of plasma membrane calcium pump activity in immortalized distal tubule kidney cells. Molecular and cellular endocrinology. 2003 Dec; 212(1-2):11-8. doi: 10.1016/j.mce.2003.09.028. [PMID: 14654246]
  • Florence Trémollières, Patrice Lopes. [Specific estrogen receptor modulators (SERMs)]. Presse medicale (Paris, France : 1983). 2002 Sep; 31(28):1323-8. doi: ". [PMID: 12355995]
  • Sumi Dinda, Amelita Sanchez, Virinder Moudgil. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene. 2002 Jan; 21(5):761-8. doi: 10.1038/sj.onc.1205136. [PMID: 11850804]
  • M Luconi, L Bonaccorsi, G Forti, E Baldi. Effects of estrogenic compounds on human spermatozoa: evidence for interaction with a nongenomic receptor for estrogen on human sperm membrane. Molecular and cellular endocrinology. 2001 Jun; 178(1-2):39-45. doi: 10.1016/s0303-7207(01)00416-6. [PMID: 11403892]
  • A E Elkak, K Mokbel. Pure antiestrogens and breast cancer. Current medical research and opinion. 2001; 17(4):282-9. doi: . [PMID: 11922402]
  • J Matthews, T Celius, R Halgren, T Zacharewski. Differential estrogen receptor binding of estrogenic substances: a species comparison. The Journal of steroid biochemistry and molecular biology. 2000 Nov; 74(4):223-34. doi: 10.1016/s0960-0760(00)00126-6. [PMID: 11162928]
  • S Nishimura, M Taki, S Takaishi, Y Iijima, T Akiyama. Structures of 4-aryl-coumarin (neoflavone) dimers isolated from Pistacia chinensis BUNGE and their estrogen-like activity. Chemical & pharmaceutical bulletin. 2000 Apr; 48(4):505-8. doi: 10.1248/cpb.48.505. [PMID: 10783069]
  • Y L Dong, C Yallampalli. Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP(2) and contractile FP receptors in the rat uterus. Biology of reproduction. 2000 Mar; 62(3):533-9. doi: 10.1095/biolreprod62.3.533. [PMID: 10684792]
  • R L van Bezooijen, I Que, A G Ederveen, H J Kloosterboer, S E Papapoulos, C W Löwik. Plasma nitrate+nitrite levels are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats. The Journal of endocrinology. 1998 Oct; 159(1):27-34. doi: 10.1677/joe.0.1590027. [PMID: 9795338]
  • Y L Dong, L Fang, P R Gangula, C Yallampalli. Regulation of inducible nitric oxide synthase messenger ribonucleic acid expression in pregnant rat uterus. Biology of reproduction. 1998 Oct; 59(4):933-40. doi: 10.1095/biolreprod59.4.933. [PMID: 9746746]
  • P T Ram, T Kiefer, M Silverman, Y Song, G M Brown, S M Hill. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Molecular and cellular endocrinology. 1998 Jun; 141(1-2):53-64. doi: 10.1016/s0303-7207(98)00095-1. [PMID: 9723886]
  • B Varriale, J Alvarez, F Prieto, P Domínguez. Hormonal regulation of FHG22 mRNA in Syrian hamster harderian glands: role of estradiol. Molecular and cellular endocrinology. 1996 Nov; 124(1-2):87-96. doi: 10.1016/s0303-7207(96)03932-9. [PMID: 9027328]
  • C M Tellería, C O Stocco, A O Stati, A M Rastrilla, D G Carrizo, L I Aguado, R P Deis. Dual regulation of luteal progesterone production by androstenedione during spontaneous and RU486-induced luteolysis in pregnant rats. The Journal of steroid biochemistry and molecular biology. 1995 Dec; 55(3-4):385-93. doi: 10.1016/0960-0760(95)00190-5. [PMID: 8541235]
  • D P McDonnell, D L Clemm, T Hermann, M E Goldman, J W Pike. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Molecular endocrinology (Baltimore, Md.). 1995 Jun; 9(6):659-69. doi: 10.1210/mend.9.6.8592512. [PMID: 8592512]
  • G Vollmer, N Ellerbrake, A C Hopert, R Knauthe, W Wünsche, R Knuppen. Extracellular matrix induces hormone responsiveness and differentiation in RUCA-I rat endometrial adenocarcinoma cells. The Journal of steroid biochemistry and molecular biology. 1995 Mar; 52(3):259-69. doi: 10.1016/0960-0760(94)00173-j. [PMID: 7696147]
  • H Wiseman, B Halliwell. Tamoxifen and related compounds protect against lipid peroxidation in isolated nuclei: relevance to the potential anticarcinogenic benefits of breast cancer prevention and therapy with tamoxifen?. Free radical biology & medicine. 1994 Nov; 17(5):485-8. doi: 10.1016/0891-5849(94)90176-7. [PMID: 7835756]
  • V Cavaillès, S Dauvois, P S Danielian, M G Parker. Interaction of proteins with transcriptionally active estrogen receptors. Proceedings of the National Academy of Sciences of the United States of America. 1994 Oct; 91(21):10009-13. doi: 10.1073/pnas.91.21.10009. [PMID: 7937828]
  • V L Davis, J F Couse, T K Gray, K S Korach. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 1994 Jul; 9(7):983-91. doi: 10.1002/jbmr.5650090705. [PMID: 7942167]
  • C J Newton, T Trapp, U Pagotto, U Renner, R Buric, G K Stalla. The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen. Journal of molecular endocrinology. 1994 Jun; 12(3):303-12. doi: 10.1677/jme.0.0120303. [PMID: 7916969]
  • R J Miksicek. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. The Journal of steroid biochemistry and molecular biology. 1994 Jun; 49(2-3):153-60. doi: 10.1016/0960-0760(94)90005-1. [PMID: 8031711]
  • S D McLeod, M Ranson, R S Mason. Effects of estrogens on human melanocytes in vitro. The Journal of steroid biochemistry and molecular biology. 1994 May; 49(1):9-14. doi: 10.1016/0960-0760(94)90295-x. [PMID: 8003445]
  • D P McDonnell, M E Goldman. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. The Journal of biological chemistry. 1994 Apr; 269(16):11945-9. doi: . [PMID: 8163495]
  • C J Newton, R Buric, T Trapp, S Brockmeier, U Pagotto, G K Stalla. The unliganded estrogen receptor (ER) transduces growth factor signals. The Journal of steroid biochemistry and molecular biology. 1994 Apr; 48(5-6):481-6. doi: 10.1016/0960-0760(94)90197-x. [PMID: 8180109]
  • H Wiseman. The antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential. Biochemical pharmacology. 1994 Feb; 47(3):493-8. doi: 10.1016/0006-2952(94)90180-5. [PMID: 8117317]
  • C K Watts, K J Sweeney, A Warlters, E A Musgrove, R L Sutherland. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast cancer research and treatment. 1994; 31(1):95-105. doi: 10.1007/bf00689680. [PMID: 7981461]
  • Y Nishino, M R Schneider, H Michna. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384. Journal of cancer research and clinical oncology. 1994; 120(5):298-302. doi: 10.1007/bf01236387. [PMID: 8126059]
  • E A Musgrove, J A Hamilton, C S Lee, K J Sweeney, C K Watts, R L Sutherland. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Molecular and cellular biology. 1993 Jun; 13(6):3577-87. doi: 10.1128/mcb.13.6.3577-3587.1993. [PMID: 8497271]
  • L Markiewicz, J Garey, H Adlercreutz, E Gurpide. In vitro bioassays of non-steroidal phytoestrogens. The Journal of steroid biochemistry and molecular biology. 1993 May; 45(5):399-405. doi: 10.1016/0960-0760(93)90009-l. [PMID: 8499347]
  • S J Santner, B Ohlsson-Wilhelm, R J Santen. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures. International journal of cancer. 1993 Apr; 54(1):119-24. doi: 10.1002/ijc.2910540119. [PMID: 8478138]
  • T E Wiese, L G Kral, K E Dennis, W B Butler, S C Brooks. Optimization of estrogen growth response in MCF-7 cells. In vitro cellular & developmental biology : journal of the Tissue Culture Association. 1992 Sep; 28A(9-10):595-602. doi: 10.1007/bf02631033. [PMID: 1429362]
  • D M Ignar-Trowbridge, K G Nelson, M C Bidwell, S W Curtis, T F Washburn, J A McLachlan, K S Korach. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proceedings of the National Academy of Sciences of the United States of America. 1992 May; 89(10):4658-62. doi: 10.1073/pnas.89.10.4658. [PMID: 1584801]
  • Y Gong, G Ballejo, L C Murphy, L J Murphy. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer research. 1992 Apr; 52(7):1704-9. doi: . [PMID: 1551100]
  • G Chetrite, J R Pasqualini. Effect of embryonic mouse cells BALB/c-3T3 on the proliferation of the human mammary cancer cell line T-47D. The Journal of steroid biochemistry and molecular biology. 1992 Mar; 41(3-8):553-6. doi: 10.1016/0960-0760(92)90382-s. [PMID: 1562526]
  • D M Ignar-Trowbridge, A R Hughes, J W Putney, J A McLachlan, K S Korach. Diethylstilbestrol stimulates persistent phosphatidylinositol lipid turnover by an estrogen receptor-mediated mechanism in immature mouse uterus. Endocrinology. 1991 Nov; 129(5):2423-30. doi: 10.1210/endo-129-5-2423. [PMID: 1935776]
  • M E Bracke, N A Van Larebeke, B M Vyncke, M M Mareel. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. British journal of cancer. 1991 Jun; 63(6):867-72. doi: 10.1038/bjc.1991.191. [PMID: 1648947]
  • A E Wakeling. Therapeutic potential of pure antioestrogens in the treatment of breast cancer. The Journal of steroid biochemistry and molecular biology. 1990 Dec; 37(6):771-5. doi: 10.1016/0960-0760(90)90418-k. [PMID: 2285589]
  • C S Murphy, J J Pink, V C Jordan. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer research. 1990 Nov; 50(22):7285-92. doi: . [PMID: 2224859]
  • J L Albert, S A Sundstrom, C R Lyttle. Estrogen regulation of placental alkaline phosphatase gene expression in a human endometrial adenocarcinoma cell line. Cancer research. 1990 Jun; 50(11):3306-10. doi: . [PMID: 2334923]
  • J R Pasqualini, C Sumida, N Giambiagi. Pharmacodynamic and biological effects of anti-estrogens in different models. Journal of steroid biochemistry. 1988 Oct; 31(4B):613-43. doi: 10.1016/0022-4731(88)90013-1. [PMID: 3059059]
  • . . . . doi: . [PMID: 10726863]